We investigated the effect of ERα and ERβ activation on transmigration across the brain endothelial cell barrier and hypothesized that treatment with selective ERβ agonists would reduce the passage of breast cancer cells across the BBB model. This evidence concerns the gene ESR1 and breast cancer.